Recurrent hospitalization among patients with atrial fibrillation undergoing intracoronary stenting treated with 2 treatment strategies of rivaroxaban or a dose-adjusted oral Vitamin K antagonist treatment strategy

C. Michael Gibson, Duane S. Pinto, Gerald Chi, Douglas Arbetter, Megan Yee, Roxana Mehran, Christoph Bode, Jonathan Halperin, Freek W.A. Verheugt, Peter Wildgoose, Paul Burton, Martin Van Eickels, Serge Korjian, Yazan Daaboul, Purva Jain, Gregory Y.H. Lip, Marc Cohen, Eric D. Peterson, Keith A.A. Fox

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Recurrent hospitalization among patients with atrial fibrillation undergoing intracoronary stenting treated with 2 treatment strategies of rivaroxaban or a dose-adjusted oral Vitamin K antagonist treatment strategy'. Together they form a unique fingerprint.

Medicine & Life Sciences